Logo image of AIFF

FIREFLY NEUROSCIENCE INC (AIFF) Stock Fundamental Analysis

NASDAQ:AIFF - Nasdaq - US3179701012 - Common Stock - Currency: USD

3.3  -0.08 (-2.37%)

After market: 3.39 +0.09 (+2.73%)

Fundamental Rating

0

Overall AIFF gets a fundamental rating of 0 out of 10. We evaluated AIFF against 37 industry peers in the Health Care Technology industry. Both the profitability and financial health of AIFF have multiple concerns. AIFF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AIFF has reported negative net income.
AIFF had a negative operating cash flow in the past year.
AIFF had negative earnings in 4 of the past 5 years.
In the past 5 years AIFF reported 4 times negative operating cash flow.
AIFF Yearly Net Income VS EBIT VS OCF VS FCFAIFF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

AIFF has a worse Return On Assets (-241.99%) than 83.78% of its industry peers.
Industry RankSector Rank
ROA -241.99%
ROE N/A
ROIC N/A
ROA(3y)-164.93%
ROA(5y)-97.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AIFF Yearly ROA, ROE, ROICAIFF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K -2K

1.3 Margins

AIFF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AIFF Yearly Profit, Operating, Gross MarginsAIFF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

0

2. Health

2.1 Basic Checks

AIFF does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIFF has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AIFF has been increased compared to 5 years ago.
Compared to 1 year ago, AIFF has a worse debt to assets ratio.
AIFF Yearly Shares OutstandingAIFF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AIFF Yearly Total Debt VS Total AssetsAIFF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

AIFF has an Altman-Z score of -28.89. This is a bad value and indicates that AIFF is not financially healthy and even has some risk of bankruptcy.
AIFF has a worse Altman-Z score (-28.89) than 86.49% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -28.89
ROIC/WACCN/A
WACC10.59%
AIFF Yearly LT Debt VS Equity VS FCFAIFF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

AIFF has a Current Ratio of 0.53. This is a bad value and indicates that AIFF is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AIFF (0.53) is worse than 81.08% of its industry peers.
A Quick Ratio of 0.53 indicates that AIFF may have some problems paying its short term obligations.
AIFF has a Quick ratio of 0.53. This is amonst the worse of the industry: AIFF underperforms 81.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
AIFF Yearly Current Assets VS Current LiabilitesAIFF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for AIFF have decreased strongly by -132.06% in the last year.
The Revenue for AIFF has decreased by -74.64% in the past year. This is quite bad
AIFF shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -59.70% yearly.
EPS 1Y (TTM)-132.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.49%
Revenue 1Y (TTM)-74.64%
Revenue growth 3Y-80.7%
Revenue growth 5Y-59.7%
Sales Q2Q%-97.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AIFF Yearly Revenue VS EstimatesAIFF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIFF. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIFF Price Earnings VS Forward Price EarningsAIFF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIFF Per share dataAIFF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIFF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIREFLY NEUROSCIENCE INC

NASDAQ:AIFF (5/21/2025, 8:00:00 PM)

After market: 3.39 +0.09 (+2.73%)

3.3

-0.08 (-2.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.84%
Inst Owner Change90.32%
Ins Owners26.07%
Ins Owner Change0%
Market Cap38.35M
AnalystsN/A
Price TargetN/A
Short Float %6.79%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.95
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.17
BVpS-0.03
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -241.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-164.93%
ROA(5y)-97.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 619.4%
Cap/Sales 20.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -28.89
F-Score2
WACC10.59%
ROIC/WACCN/A
Cap/Depr(3y)218.97%
Cap/Depr(5y)257.21%
Cap/Sales(3y)129.58%
Cap/Sales(5y)77.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.64%
Revenue growth 3Y-80.7%
Revenue growth 5Y-59.7%
Sales Q2Q%-97.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-240.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-133.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.68%
OCF growth 3YN/A
OCF growth 5YN/A